Trump’s push to onshore pharma manufacturing clouded by ‘lack of clarity’
Questions remain as to how FDA inspection differences between domestic and foreign drug facilities will play out.
Odyssey bails on public listing as US IPO landscape stutters
Outlook’s wet AMD treatment accepted by SMC for NHS Scotland
Mosanna Therapeutics gains $80m to advance OSA nasal spray
RFK Jr axes vaccine advisory committee members
MSD receives FDA approval for Enflonsia to prevent RSV
Analysis
View More
Themes
View MoreJuvenescence enhances AI drug discovery with Ro5 acquisition
The platform enables evaluation of drug targets based on therapeutic, biological and market potential.
More themes
Data Insights
View MoreCell & gene therapy: the leading companies in recombinant AAV gene therapy revealed
The pharmaceutical industry continues to be a hotbed of patent innovation. Activity is driven by the evolution of treatment paradigms,...
Discover Data Insights powered by our proprietary data
Understand the themes driving your sector, keep up with key innovation areas and track the activities of leading companies
More Insights
Buyer's Guides
View More
Digital health and digital therapeutics (DTx) services and providers for the pharmaceutical industry
GlobalData Reports
View More
Digital Magazine
View MorePharma Technology Focus
Pharma Technology Focus is our digital magazine, free to read online on all devices. Click the magazine cover to read the latest issue. You can subscribe for free to have each new issue delivered to your inbox.
Pharma’s AI prospects get nudged into the future with EU’s AI act
Next-generation targeting for evolving HCP engagement
Are regulators keeping pace with AI adoption in clinical trials?
Recursion axes drug programmes to streamline pipeline